These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1147 related articles for article (PubMed ID: 2564228)

  • 1. Tyrosinase activity in serum from patients with malignant melanoma.
    Agrup P; Carstam R; Wittbjer A; Rorsman H; Rosengren E
    Acta Derm Venereol; 1989; 69(2):120-4. PubMed ID: 2564228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum tyrosinase in malignant disease, its activity, and the electrophoretic patterns of the enzyme as carried by immunoglobulins'.
    Chen YM; Lim BT; Chavin W
    Cancer Res; 1979 Sep; 39(9):3485-90. PubMed ID: 113092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological determination of tyrosinase in sera of melanoma-bearing hamsters.
    Dernałowicz-Malarczyk E; Kotłowska-Niećko I
    Neoplasma; 1980; 27(4):345-53. PubMed ID: 6779209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heterogeneity of tyrosinases isolated from rat skin, normal human skin, and human melanoma tumors].
    Sukhanov VA; D'iakov VL; Lalaev VV; Iakh''iaev AV
    Biokhimiia; 1991 Jun; 56(6):1026-35. PubMed ID: 1932336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of tyrosinase mRNA from the blood of melanoma patients.
    Stevens GL; Scheer WD; Levine EA
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):293-6. PubMed ID: 8722221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of human tyrosinase from cultured melanoma cells.
    Wittbjer A; Dahlbäck B; Odh G; Rosengren AM; Rosengren E; Rorsman H
    Acta Derm Venereol; 1989; 69(2):125-31. PubMed ID: 2564229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical markers of malignant melanoma.
    Matous B; Cigánek EF; Budĕsínská A; Duchon J
    Neoplasma; 1987; 34(1):77-84. PubMed ID: 3104808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An animal model for the survival of tyrosinase isozymes in serum.
    Vachtenheim J; Duchon J; Matous B
    Arch Dermatol Res; 1984; 276(2):111-4. PubMed ID: 6426408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosinase activity in the sera of patients with malignant melanoma: method and specificity.
    Nishioka K; Romsdahl MM; Fritsche HA; McMurtrey MJ
    Int J Cancer; 1977 Nov; 20(5):689-93. PubMed ID: 411760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosinase activity in the serum of patients with malignant melanoma.
    Sonesson B; Eide S; Ringborg U; Rorsman H; Rosengren E
    Melanoma Res; 1995 Apr; 5(2):113-6. PubMed ID: 7620338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopa oxidase activity and ceruloplasmin in the sera of hamsters with melanoma.
    Vachtenheim J; Pavel S; Duchon J
    Neoplasma; 1981; 28(1):59-65. PubMed ID: 6792550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of the determination of serum markers in patients with malignant melanoma.
    Lugović L; Situm M; Buljan M; Poduje S; Sebetić K
    Coll Antropol; 2007 Jan; 31 Suppl 1():7-11. PubMed ID: 17469741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
    Visús C; Andres R; Mayordomo JI; Martinez-Lorenzo MJ; Murillo L; Sáez-Gutiérrez B; Diestre C; Marcos I; Astier P; Godino J; Carapeto-Marquez de Prado FJ; Larrad L; Tres A
    Melanoma Res; 2007 Apr; 17(2):83-9. PubMed ID: 17496783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunohistochemical demonstration of tyrosinase 4 in normal skin and melanocytic tumors].
    Kageshita T; Ono T; Arao T; Tomita Y
    Nihon Hifuka Gakkai Zasshi; 1987 May; 97(6):685-90. PubMed ID: 3114516
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of dinitrophenylation on the tyrosinase activity of extracts from human melanomas].
    Schwartze G
    Dermatol Monatsschr; 1986; 172(8):498-500. PubMed ID: 3095156
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative analysis of tyrosinase and tyrosinase-related protein-2 mRNA from melanoma cells in blood by real-time polymerase chain reaction.
    Johansson M; Arstrand K; Håkansson A; Lindholm C; Kågedal B
    Melanoma Res; 2000 Jun; 10(3):213-22. PubMed ID: 10890374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosinase activity and isoenzyme distribution corresponding to growth and regression of melanoma in Sinclair miniature swine.
    Kovacs SA; Geekie KM; Oxenhandler RW; Agris PF
    J Natl Cancer Inst; 1981 Sep; 67(3):645-51. PubMed ID: 6792414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tyrosinase and dopa oxidase in amelanotic melanoma in man].
    Chicewicz M; Roczniak E
    Wiad Lek; 1977 Aug; 30(15):1187-91. PubMed ID: 410164
    [No Abstract]   [Full Text] [Related]  

  • 19. [Malignant melanoma--a PO-cell tumor? (author's transl)].
    Schmidt H; Stintz AR
    Arch Geschwulstforsch; 1975; 45(2):146-52. PubMed ID: 812451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative determination of phenoloxidase (EC 1.14.18.1). Spectrophotometry measurement of the activity of mushroom and potato tyrosinase].
    Schmidt H
    Dermatol Monatsschr; 1990; 176(12):757-61. PubMed ID: 2128830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.